What is the annual revenue of chemed?
Chemed Corporation records annual revenues scaling approximately between USD 2.5 billion and USD 2.6 billion, driven by the robust performance of its two primary operating divisions: VITAS Healthcare and Roto-Rooter. VITAS, which represents the nation's largest provider of end-to-end hospice care, consistently generates a significant majority of total corporate revenue through continuous expansion in patient admissions and average daily census metrics. Meanwhile, Roto-Rooter contributes steady commercial and residential plumbing and drain cleaning service revenues. Financial disclosures highlight resilient top-line growth, backed by strong operating cash flows, disciplined capital allocation strategies, and regular updates to full-year earnings and revenue guidance frameworks.
Related FAQs
Wall Street analyst consensus price targets for Chemed Corporation (NYSE: CHE) average approximately $610.00, reflecting positive outlooks from healthcare and service sector researchers.
Identifying three specific equities to purchase at any given moment requires balancing robust fundamental growth drivers, solid balance sheets, and competitive market positioning across diverse economic sectors.
Chemed Corporation trades at a price-to-earnings ratio of approximately 22.5 to 24.6, sitting comfortably below its 10-year historical average.
Chemed Corporation is a diversified operational holding company headquartered in Cincinnati, Ohio, that manages two core wholly-owned subsidiary enterprises.
Chord Energy Corporation demonstrates strong operational and financial performance, highlighted by recent quarterly earnings reports that significantly surpassed Wall Street consensus estimates for both earnings per share and total revenues.
Chemed Corporation provides specialized, non-acute healthcare services through its primary operating subsidiary, Vitas Healthcare, which is the nation's largest provider of hospice care in the United States.
Chemed Corporation officially finalized its acquisition of VITAS Healthcare Corporation on February 24, 2004.
Chemed Corporation (NYSE: CHE) trades at $540.57 per share.
Chemed Corporation operates across two distinct business segments, each facing dedicated industry rivals.
Chemed Corporation belongs to the Healthcare sector.
Equity research analysts project steady long-term growth prospects for Chemed Corporation, anchored by the consistent operational performance of its two primary operating segments: VITAS Healthcare and Roto-Rooter.
Chemed Corporation is a diversified operational enterprise that manages prominent subsidiary companies operating primarily in specialized healthcare and residential services, most notably VITAS Healthcare (the largest provider of hospice care in the ...
The corporate brand name Chemed (referring to Chemed Corporation) originated historically as a portmanteau abbreviation combining linguistic elements of Chemical and Medical enterprises during its early corporate evolution.